Manufactured at the moment of need. No cold chain. No centralized plant. No inventory sitting between patient and compound.
Autonom moves manufacturing to where the patient is — clinic, pharmacy, research lab. The supply chain collapses to a single cycle.
Compound, dose, and formulation configured per patient. What centralized manufacturing cannot do by design, Autonom does by default.
Proprietary biopolymer cassette. Pre-loaded, factory-sealed, human-safe. You supply the compound — Autonom fabricates on demand.
First units Q4 2026. Pharmacies, clinics, research labs, and platform partners.